Powered by

Two Research Studies Supported by Medidata to be Presented at ASH 2018

Nov 20, 2018 - Business Wire

The Castleman Disease Collaborative Network (CDCN) will present results of a large-scale proteomics study of idiopathic multicentric Castleman disease (iMCD), supported by Medidata Rave Omics, at the 60th Annual Meeting of the American Society of Hematology. The CDCN will also share an overview of its poster presentation and abstract at the Medidata (NASDAQ: MDSO) booth (#257).

The CDCN, a global non-profit organization dedicated to accelerating research and treatments for Castleman diseas...